Sarepta Therapeutics receives a revised brokerage price outlook, drawing market attention toward the rare disease biotechnology segment. Institutional capital repositioning across biotechnology ...

Scientists have developed Evo 2, a powerful AI model that can analyze and generate DNA sequences across all domains of life.

Dyne Therapeutics (NasdaqGS:DYN) has initiated the Phase 3 Harmonia trial of DYNE-101 in myotonic dystrophy type 1, following alignment with the FDA on the study design. The Harmonia trial is a ...

Every second, hundreds to thousands of molecules move through thousands of nuclear pores in each of your cells. A new high-definition view reveals the machine in action.

For decades, cancer immunotherapy has focused primarily on CD8+ cytotoxic T lymphocytes as the main executors of tumor cell ...

A remarkably small bacterium containing fewer than 500 genes serves as the basis for one of the most detailed digital life ...

An important study has uncovered an unexpected molecular player that helps make cancer cells stress-resilient, thereby promoting the survival, growth and progression of tumours. Researchers have ...

They’re tenacious, which is very good for a milk jug or a car bumper. But they don’t easily break down, which is bad for the environment. From the 1950s, when plastics were first produced in ...

CD4+ T cells, long regarded as supporting actors in cancer immunity, are emerging as central regulators of tumor control and ...

Inside each of your cells lies a nucleus, its master command center. Protected inside each nucleus are your chromosomes, ...

This article explains how diet creates sustained epigenetic changes that affect long-term health, disease risk, aging, and ...